Stephen G. Jenkins, Ph.D., a clinical microbiologist for over 35 years, currently serves as Director of the Clinical Microbiology Laboratories at New York Presbyterian Hospital Hospital/Weill Cornell Medical Center and as a Professor in the Department of Pathology and Laboratory Medicineas well as a Professor of Pathology in Medicine at the Weill Cornell Medical College in New York, NY.Dr Jenkins obtained his Ph.D. in Medical Microbiology at the University of Vermont and did his postdoctoral residency in Clinical and Public Health Microbiology at the Mount Sinai Medical Center in Milwaukee, WI.In addition to his current appointment, Dr. Jenkins has held past faculty appointments as Professor of Pathology and Professor of Medicine at the Mount Sinai School of Medicine in New York, NY, as an Associate Professor of Pathology and as an Associate Professor of Medicine at the University of Florida College of Medicine as well as serving as Global Director of Microbiology and interim Global Director of Anti-infectives for Aventis Pharmaceuticals, in which capacity he was largely involved in the clinical trials and successful FDA submission of the antimicrobial agent telithromycin.Dr. Jenkins has published 16 textbook chapters and served as a section editor for the the Clinical Microbiology Procedures Handbook. Additionally he has co-authored twenty CLSI Standards, authored or co-authored over 135 articles in such peer-reviewed journals as Emerging Infectious Diseases, the Journal of Antimicrobial Chemotherapy, the Journal of Medical Microbiology, Transplantation, Pediatrics, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, Reviews in Medical Microbiology, Clinical Nephrology; the Annals of Otology, Rhinology, and Laryngology, Diagnostic Microbiology and Infectious Disease, the Southern Medical Journal, Obstetrics and Gynecology, the Journal of Clinical Microbiology, the European Journal of Clinical Microbiology and Infectious Diseases, the Pediatric Infectious Disease Journal, the Journal of Infectious Diseases, the British Journal of Haematology, and the American Journal of Medicine. In addition he has authored 21 monographs and invited articles and 150 abstracts, presented at national and international professional society meetings.Dr. Jenkins lectures widely, both nationally and internationally, and in 2004 was an invited speaker for the National Foundation for Infectious Diseases both at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and the Infectious Disease Society of America (IDSA) annual meetings.Dr. Jenkins has served as a Reviewer for a number of professional journals including the Journal of Clinical Microbiology, the Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, the Annals of Internal Medicine, Digestive Diseases, Clinical Microbiology Reviews, the International Journal of Antimicrobial Agents, Clinical Microbiology and Infection, ASM News, Anaerobe, Mayo Clinic Proceedings, and Diagnostic Microbiology and Infectious Diseases, and currently serves on the Editorial Board of the journal Anaerobe.A Fellow of the American Academy of Microbiology and a Diplomate of the American Board of Medical Microbiology in Public Health and Medical Microbiology, he  additionally holds or has held a host of positions in professional organizations and societies including Chairman of the American Board of Medical Microbiology, the Board of Governors of the American Academy of Microbiology; Chairman of the American Board of Medical Microbiology Standards and Examination Committee, Chairman of Division C (Clinical Microbiology) of the American Society for Microbiology; the Clinical Laboratory Standards Institute (CLSI) Area Committee on Microbiology, the CLSI Subcommittee on Antimicrobial Susceptibility Testing (SAST), the CLSI SAST Working Group on Anaerobes, the CLSI SAST Working Group on the Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data, the CLSI SAST Working Group on Clinical Studies, as chair of the CLSI SAST Enterobacteriaceae Working Group and as co-chair of the CLSI SAST Methodology Working Group, as well as a member of  the ICAAC Program Committee.